Hybrid Cancer Neuroscience Symposium 2024

MD Anderson Cancer Center presents a two-day hybrid symposium featuring contributions from over 30 leading international experts focused on Cancer Neuroscience. Be part of a groundbreaking scientific event that will integrate neuroscience, cancer biology and aging science to spur a wave of innovation in cancer research and care. Building on our previous meeting with over 1200 participants as well as collaborative research and discussion among our speakers, the goal of this meeting is to explore how the interface between cancer biology and neuroscience impacts tumor development, progression and health outcomes.

This 2nd Cancer Neuroscience Symposium will leverage advances in neuroscience, as well as advances in immuno-oncology and aging. This meeting will cover emerging areas, such as neuro-immune interactions, plasticity within the tumor microenvironment, and translational research. This meeting will bring together leading experts from across the fields of neuroscience, cancer biology, immunology, and the biology of aging, as well as oncologists, surgeons, neurologists, patients and patient advocates to facilitate discussions of exciting new concepts and developments in this rapidly growing field.

CNS 2024: Satellite Meeting on Clinical Cancer Neuroscience

The 2024 Satellite Meeting of the Cancer Neuroscience Symposium will be held virtually on February 28, 2024. Talks will present translational and clinical innovations in cancer neuroscience. Speakers will discuss advances in neurotoxicities during cancer therapies, mental health and pain effects from cancer and cancer therapies, a clinical trial panel, and a meet the editor session.  The satellite meeting aims to cross-fertilize the breadth of cancer neuroscience presented at the primary cancer neuroscience symposium.

Registration and more information you can find here.